Pesquisas alternativas:
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
after arm » after warm (Expandir a Pesquisa), after harm (Expandir a Pesquisa), after art (Expandir a Pesquisa)
arm phase » from phase (Expandir a Pesquisa), m phase (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
after arm » after warm (Expandir a Pesquisa), after harm (Expandir a Pesquisa), after art (Expandir a Pesquisa)
arm phase » from phase (Expandir a Pesquisa), m phase (Expandir a Pesquisa)
241
Por Hochhaus, A, Saglio, G, Hughes, T P, Larson, R A, Kim, D-W, Issaragrisil, S, le Coutre, P D, Etienne, G, Dorlhiac-Llacer, P E, Clark, R E, Flinn, I W, Nakamae, H, Donohue, B, Deng, W, Dalal, D, Menssen, H D, Kantarjian, H M
Publicado no Leukemia (2016)
“...In the phase 3 Evaluating Nilotinib Efficacy and Safety in Clinical Trials–Newly Diagnosed Patients...”Publicado no Leukemia (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
242
Por Lim, Sean H., Linton, Kim M., Collins, Graham P., Dhondt, Joke, Caddy, Joshua, Rossiter, Liz, Vadher, Karan, Fines, Keira, Rogers, Laura E., Fernando, Diana, Stanton, Louise, Davies, Andrew J., Johnson, Peter W. M., Griffiths, Gareth
Publicado no Trials (2018)
“... and potentially curable cancer, approximately 30% of DLBCL cases will relapse after frontline therapy. Advanced...”Publicado no Trials (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
243
Por Satoh, Takefumi, Uemura, Hiroji, Tanabe, Kazunari, Nishiyama, Tsutomu, Terai, Akito, Yokomizo, Akira, Nakatani, Tatsuya, Imanaka, Keiichiro, Ozono, Seiichiro, Akaza, Hideyuki
Publicado no Jpn J Clin Oncol (2014)
“... (prostate-specific antigen response rate) after 12-week treatment. Safety and pharmacokinetics were also...”Publicado no Jpn J Clin Oncol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
244
Por Tanimura, Keiko, Uchino, Junji, Tamiya, Nobuyo, Kaneko, Yoshiko, Yamada, Tadaaki, Yoshimura, Kenichi, Takayama, Koichi
Publicado no Medicine (Baltimore) (2018)
“... prospective, multicenter, open-label, single-arm phase II study designed to evaluate efficacy and safety...”Publicado no Medicine (Baltimore) (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
245
Por Garcia-Aguilar, Julio, Shi, Qian, Thomas, Charles R., Chan, Emily, Cataldo, Peter, Marcet, Jorge, Medich, David, Pigazzi, Alessio, Oommen, Samuel, Posner, Mitchell C.
Publicado no Ann Surg Oncol (2011)
“...PURPOSE: We designed ACOSOG Z6041, a prospective, multi-center, single-arm, Phase II trial...”Publicado no Ann Surg Oncol (2011)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
246
Por Raymond, Eric, Brandes, Alba A., Dittrich, Christian, Fumoleau, Pierre, Coudert, Bruno, Clement, Paul M.J., Frenay, Marc, Rampling, Roy, Stupp, Roger, Kros, Johan M., Heinrich, Michael C., Gorlia, Thierry, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2008
“.... PATIENTS AND METHODS: This was a single-arm, phase II study. Eligible patients had recurrent glioma after...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
247
Por Long, G. V., Atkinson, V., Ascierto, P. A., Robert, C., Hassel, J. C., Rutkowski, P., Savage, K. J., Taylor, F., Coon, C., Gilloteau, I., Dastani, H. B., Waxman, I. M., Abernethy, A. P.
Publicado no Ann Oncol (2016)
“... completion rates for all HRQoL questionnaires across treatment arms were 65% and 70% for dacarbazine...”Publicado no Ann Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
248
Por Dotan, Efrat, Meropol, Neal J., Burtness, Barbara, Denlinger, Crystal S., Lee, James, Mintzer, David, Zhu, Fang, Ruth, Karen, Tuttle, Holly, Sylvester, Judi, Cohen, Steven J.
Publicado em 2012
“..., with expected higher rates of grade 1/2 hypertension and bleeding in Arm A. The overall response rate was 54...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
249
Por Hurt, CN, Jones, SEF, Madden, T‐A, Fiander, A, Nordin, AJ, Naik, R, Powell, N, Carucci, M, Tristram, A
Publicado no BJOG (2018)
“...OBJECTIVE: To compare the recurrence rates after complete response to topical treatment with either...”Publicado no BJOG (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
250
Por Lu, Ming, Wang, Xicheng, Shen, Lin, Jia, Jun, Gong, Jifang, Li, Jie, Li, Jian, Li, Yan, Zhang, Xiaotian, Lu, Zhihao, Zhou, Jun, Zhang, Xiaodong
Publicado no Cancer Sci (2016)
“.... This prospective, single‐armed, open label phase II study was conducted to evaluate the efficacy and safety...”Publicado no Cancer Sci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
251
Por Goss, Glenwood, Ferry, David, Wierzbicki, Rafal, Laurie, Scott A., Thompson, Joyce, Biesma, Bonne, Hirsch, Fred R., Varella-Garcia, Marileila, Duffield, Emma, Ataman, Ozlem U., Zarenda, Marc, Armour, Alison A.
Publicado no J Clin Oncol (2009)
“...), objective response rate (ORR), quality of life (QOL), pulmonary symptom improvement (PSI), and safety...”Publicado no J Clin Oncol (2009)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
252
Por Zheng, Yi, Tu, Xiaoxuan, Zhao, Peng, Jiang, Weiqin, Liu, Lulu, Tong, Zhou, Zhang, Hangyu, Yan, Cong, Fang, Weijia, Wang, Weilin
Publicado no Br J Cancer (2018)
“... and IRI-arms, respectively, the median PFS was 3.7 vs. 2.4 months, 9-month survival rate 60.9% vs. 32.0...”Publicado no Br J Cancer (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
253
Por Glas, M, Scheffler, B, Lazaridis, L, Herrlinger, U, Pierscianek, D, Sure, U, Pröscholdt, M, Hau, P, Hense, J, Kleinschnitz, C, Grosu, A, Stuschke, M, Kebir, S
Publicado no Neuro Oncol (2018)
“... survival (PFS), overall survival (OS) and long-term survival rates in the EF-14 phase III trial...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
254
Por Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L
Publicado no Ann Oncol (2018)
“...: Bevacizumab combined with CT was safe and efficient. Both arms met the primary safety and efficacy criteria....”Publicado no Ann Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
255
Por Engel-Riedel, Walburga, Lowe, Jamie, Mattson, Paulette, Richard Trout, J., Huhn, Richard D., Gargano, Michele, Patchen, Myra L., Walsh, Richard, Trinh, My My, Dupuis, Mariève, Schneller, Folker
Publicado no J Immunother Cancer (2018)
“...-cancer immune response in combination with oncology antibody therapies. This phase II study explored...”Publicado no J Immunother Cancer (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
256
Por Yu, Jeong Il, Park, Hee Chul, Jung, Sang Hoon, Choi, Changhoon, Shin, Sung Wook, Cho, Sung Ki, Sinn, Dong Hyun, Paik, Yong-Han, Gwak, Geum-Youn, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Yoo, Byung Chul, Sahinbas, Hüseyin, Paik, Seung Woon
Publicado no Oncotarget (2017)
“..., prospective phase II study was performed from October 2013 to February 2016. The objective response rate (ORR...”Publicado no Oncotarget (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
257
Por Struller, Florian, Horvath, Philipp, Solass, Wiebke, Weinreich, Frank-Jürgen, Strumberg, Dirk, Kokkalis, Marios K., Fischer, Imma, Meisner, Christoph, Königsrainer, Alfred, Reymond, Marc A.
Publicado no Ther Adv Med Oncol (2019)
“... intravenous chemotherapy. METHODS: In this open-label, single-arm, monocentric phase II ICH-GCP clinical trial...”Publicado no Ther Adv Med Oncol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
258
Por Lee, Choong-kun, Jung, Minkyu, Choi, Hye Jin, Kim, Hye Ryun, Kim, Hyo Song, Roh, Mi Ryung, Ahn, Joong Bae, Chung, Hyun Cheol, Heo, Su Jin, Rha, Sun Young, Shin, Sang Joon
Publicado no Cancer Res Treat (2015)
“... modest efficacy. MATERIALS AND METHODS: We conducted a phase II, open-label, single-arm study to test...”Publicado no Cancer Res Treat (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
259
Por Lester, Jason F, Casbard, Angela C, Al-Taei, Saly, Harrop, Richard, Katona, Lajos, Attanoos, Richard L, Tabi, Zsuzsanna, Griffiths, Gareth O
Publicado no Oncoimmunology (2018)
“... chemotherapy in malignant pleural mesothelioma (MPM). In this first line, open-label, single-arm, phase 2 study...”Publicado no Oncoimmunology (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
260
Por Fountzilas, George, Kotoula, Vassiliki, Pectasides, Dimitrios, Kouvatseas, George, Timotheadou, Eleni, Bobos, Mattheos, Mavropoulou, Xanthipi, Papadimitriou, Christos, Vrettou, Eleni, Raptou, Georgia, Koutras, Angelos, Razis, Evangelia, Bafaloukos, Dimitrios, Samantas, Epaminontas, Pentheroudakis, George, Skarlos, Dimosthenis V.
Publicado em 2013
“...To explore the activity and safety of two schedules of ixabepilone, as first line chemotherapy...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo